Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›LEO Pharma A/S

Medicines register · Ireland

LEO Pharma A/S — licensed medicines

20 medicines held by LEO Pharma A/S on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 04 Oct 2026, 10:12 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Adtralza 150 mg solution for injection in pre-filled syringe EU/1/21/1554/001-003

Tralokinumab

—

Adtralza 300 mg solution for injection in pre-filled pen EU/1/21/1554/004-005

Tralokinumab

—

Anzupgo 20 mg/g cream EU/1/24/1851/001-002

Delgocitinib

—

Dovobet 50 microgram/g + 0.5 mg/g gel PA1025/001/002

Calcipotriol, Betamethasone

Marketed

Dovobet® 50 microgram/g + 0.5 mg/g ointment PA1025/001/001

Calcipotriol, Betamethasone

Not marketed

Enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam PA1025/005/001

Calcipotriol, Betamethasone

Marketed

Kyntheum 210 mg solution for injection in pre-filled syringe EU/1/16/1155/001

Brodalumab

—

Protamine sulphate LEO Pharma 1400 anti-heparin IU/ml solution for injection and infusion PA1025/002/001

Protamine sulphate

Marketed

Protopic 0.03% ointment EU/1/02/201/001

Tacrolimus

—

Protopic 0.03% ointment EU/1/02/201/002

Tacrolimus

—

Protopic 0.03% ointment EU/1/02/201/005

Tacrolimus

—

Protopic 0.1% ointment EU/1/02/201/003

Tacrolimus

—

Protopic 0.1% ointment EU/1/02/201/004

Tacrolimus

—

Protopic 0.1% ointment EU/1/02/201/006

Tacrolimus

—

Skinoren 15% Gel PA1025/009/001

Azelaic acid

Marketed

Spevigo 150 mg solution for injection in pre-filled syringe EU/1/22/1688/002

Spesolimab

—

Spevigo 300 mg solution for injection in pre-filled syringe EU/1/22/1688/003

Spesolimab

—

Spevigo 450 mg concentrate for solution for infusion EU/1/22/1688/001

Spesolimab

—

Travocort 0.1 + 1% w/w Cream PA1025/012/001

DIFLUCORTOLONE VALERATE, Isoconazole nitrate

Marketed

Xamiol 50 micrograms/g + 0.5 mg/g gel PA1025/003/001

Calcipotriol, Betamethasone

Not marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 4 October 2026. https://priyalifescience.com/medicines/company/leo-pharma-a-s

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.